bf/NASDAQ:ACER_icon.jpeg

NASDAQ:ACER

Acer Therapeutics Inc.

  • Stock

USD

Last Close

0.80

20/11 20:59

Market Cap

16.15M

Beta: 0.57

Volume Today

574.67K

Avg: 328.16K

PE Ratio

−0.27

PFCF: −0.41

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
net income
-15.05M
-
-12.02M
20.15%
-7.98M
33.61%
-14.19M
77.87%
-21.28M
49.92%
-29.42M
38.24%
-22.89M
22.21%
-15.37M
32.82%
-26.24M
70.66%
depreciation and amortization
387.78K
-
351.40K
9.38%
238.13K
32.24%
4.00K
98.32%
27.74K
594.12%
58.28K
110.07%
70.81K
21.50%
70.91K
0.14%
66.03K
6.88%
deferred income tax
2.08K
-
122.58K
-
stock based compensation
418.09K
-
1.32M
215.28%
2.61M
98.22%
2.22M
14.88%
2.29M
2.83%
1.84M
19.52%
change in working capital
-797.00K
-
241.08K
130.25%
-3.24M
1,442.22%
-569.88K
82.39%
3.35M
687.35%
-2.82M
184.18%
3.08M
209.35%
13.45M
336.51%
-7.40M
155.02%
accounts receivables
-5M
-
5M
200%
inventory
-1.77M
-
accounts payables
6.34K
-
37.36K
489.30%
-361.89K
1,068.77%
-287.54K
20.55%
937.96K
426.20%
-472.74K
150.40%
1.11M
335.02%
-266.38K
123.98%
2.41M
1,003.82%
other working capital
-803.34K
-
203.72K
125.36%
-2.87M
1,510.69%
-282.34K
90.18%
2.41M
953.32%
-2.34M
197.33%
1.97M
184.02%
20.49M
939.82%
-14.81M
172.28%
other non cash items
1.27M
-
915.10K
27.72%
1.77M
93.94%
246.96K
86.08%
57.58K
-
359.23K
523.90%
-568.91K
258.37%
1.48M
360.08%
net cash provided by operating activities
-14.20M
-
-10.51M
25.95%
-9.20M
12.45%
-14.10M
53.16%
-16.59M
17.68%
-29.51M
77.88%
-17.03M
42.29%
-134.91K
99.21%
-30.25M
22,323.93%
investments in property plant and equipment
-190.86K
-
-92.33K
51.62%
-1.22K
98.68%
-62.84K
5,046.76%
-95.63K
52.17%
-178.97K
87.15%
-10.90K
93.91%
-54.94K
403.98%
-171.17K
211.54%
acquisitions net
1.03M
-
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-190.86K
-
-92.33K
51.62%
-1.22K
98.68%
967.28K
79,320.39%
-95.63K
109.89%
-178.97K
87.15%
-10.90K
93.91%
-54.94K
403.98%
-171.17K
211.54%
debt repayment
-186.71K
-
-724.93K
-
common stock issued
648.17K
-
13.28M
1,949.14%
276.91K
97.92%
21.51M
7,666.67%
42.62M
98.18%
10.16M
-
3.14M
69.10%
8.91M
183.84%
common stock repurchased
-5.03K
-
dividends paid
other financing activites
4.41K
-
-24.78K
661.84%
5.43M
22,021.42%
87.66K
98.39%
92.27K
5.26%
562.48K
509.59%
4M
611.14%
11.86M
196.42%
net cash used provided by financing activities
648.17K
-
13.28M
1,949.05%
65.43K
99.51%
26.94M
41,071.82%
42.71M
58.55%
92.27K
99.78%
10.72M
11,520.26%
7.14M
33.42%
20.04M
180.73%
effect of forex changes on cash
net change in cash
-13.74M
-
2.68M
119.49%
-9.14M
441.33%
13.81M
251.12%
26.03M
88.46%
-29.59M
213.70%
-6.32M
78.66%
6.95M
210.02%
-10.38M
249.39%
cash at beginning of period
23.64M
-
9.91M
58.10%
12.58M
27.03%
1.83M
85.43%
15.64M
753.01%
41.67M
166.37%
12.08M
71.02%
5.76M
52.30%
12.71M
120.61%
cash at end of period
9.91M
-
12.58M
27.03%
3.44M
72.62%
15.64M
354.12%
41.67M
166.37%
12.08M
71.02%
5.76M
52.30%
12.71M
120.61%
2.33M
81.68%
operating cash flow
-14.20M
-
-10.51M
25.95%
-9.20M
12.45%
-14.10M
53.16%
-16.59M
17.68%
-29.51M
77.88%
-17.03M
42.29%
-134.91K
99.21%
-30.25M
22,323.93%
capital expenditure
-190.86K
-
-92.33K
51.62%
-1.22K
98.68%
-62.84K
5,046.76%
-95.63K
52.17%
-178.97K
87.15%
-10.90K
93.91%
-54.94K
403.98%
-171.17K
211.54%
free cash flow
-14.39M
-
-10.60M
26.29%
-9.20M
13.20%
-14.16M
53.82%
-16.68M
17.84%
-29.69M
77.94%
-17.04M
42.60%
-189.85K
98.89%
-30.42M
15,924.54%

All numbers in USD (except ratios and percentages)